Going Home With Naloxone After Residential Treatment: How to Get It in California, Where to Keep It, and the Two-Dose Rule

, , ,
signs of fentanyl overdose

Most discharge plans from residential treatment cover the big items: aftercare appointments, a sober-living or home arrangement, medications, and a relapse prevention plan. One item is easy to treat as an afterthought, and it should not be: leaving with naloxone, and making sure the people at home know how to use it. This post walks through the logistics in California, how to get it, where to keep it, how the two-dose instruction works, and the household check to run on your first night home.

The Short Version

Naloxone is a medication that can temporarily reverse an opioid overdose, and in March 2023 the U.S. Food and Drug Administration approved 4 mg naloxone nasal spray for sale over the counter, without a prescription. The package directions tell the person responding to call 911, give one spray into one nostril, and, if the person does not respond within 2 to 3 minutes, give a second dose in the other nostril using a new device. Because naloxone can wear off before the opioid does, the person still needs emergency medical care even after they wake up. Anyone leaving residential treatment for an opioid use disorder, or for any substance use where the supply could contain fentanyl, should go home with at least two doses, and at least two other people in the household should know exactly where those doses are kept.

Why the Weeks After Discharge Carry Real Risk

Federal health agencies, including the National Institute on Drug Abuse and the Centers for Disease Control and Prevention, describe several factors that raise overdose risk after a period without opioids. Each one applies directly to someone finishing a residential stay:

  • Lost tolerance: After weeks without opioids, the body no longer handles the amount a person used before, so returning to a familiar dose can stop breathing.
  • Unknown supply: Fentanyl is now found in pills, powders, and stimulants sold as something else, so a person who never intended to use an opioid can still be exposed to one.
  • Using alone: A return to use after treatment is often hidden out of shame, which means no one is in the room to respond.
  • Mixing with sedatives: Alcohol and benzodiazepines slow breathing on their own, and combined with opioids the effect compounds.

None of this means a return to use is expected. Many people leave residential care with strong plans and never need naloxone. It means the cost of having it and not needing it is very low, and the cost of needing it and not having it is not.

What We See in Discharge Planning

From my vantage point as a certified addiction counselor and interventionist who sits in on discharge planning, the most common gap is not that the person has no naloxone. It is that the naloxone exists, but only the person in recovery knows where it is. It is in their backpack, their glove box, or a bathroom drawer, and the parent, partner, or roommate who would actually find them has never held the device. In an overdose, the person who needs the naloxone cannot give it to themselves. The plan has to live with the people around them.

The second gap we see is embarrassment on both sides. Families worry that bringing naloxone home signals they expect a relapse. People in recovery worry the same thing. We encourage families to frame it the way they would a fire extinguisher: it is in the kitchen because the house matters, not because anyone plans a fire. Our residential treatment team treats this as a standard part of the discharge conversation rather than a special warning.

How to Get Naloxone in California

There are several routes, and most people can have it in hand the same day:

  • Over the counter: Since the 2023 FDA approval, 4 mg nasal spray is sold on pharmacy shelves and at many retail stores without a prescription.
  • From a pharmacist: California law allows pharmacists to furnish naloxone directly without a prescription from a doctor, which can matter if you want a different formulation or want to bill insurance.
  • Through insurance: Many health plans cover naloxone when a prescription is written. Ask the treatment program’s prescriber whether a prescription can be sent to your pharmacy before discharge so the cost question is settled in advance.
  • Through community programs: County public health departments and community organizations in California often distribute naloxone at no cost. The SAMHSA National Helpline can point you to local resources.

If you are still arranging admission or discharge and want help sorting out the logistics, you can reach our admissions team at (877) 328-1968.

Where to Keep It and What to Check

Naloxone nasal spray should be stored at room temperature, out of direct sunlight, and in its original packaging. Hot cars are a common problem in California summers, so a car should not be the only place a household keeps it. Every package carries an expiration date. Write that date somewhere you will see it, such as a phone calendar reminder a month before it expires.

Pick one fixed, visible spot in the home, such as the kitchen or the main bathroom, and keep it there. A second set can go in the bag of the person in recovery. The rule is that everyone in the house can name the location without thinking.

The Two-Dose Instruction, Step by Step

Follow the directions printed on the package you have, because they are the authoritative version for that product. For the common 4 mg nasal spray, the steps generally look like this:

  1. Try to wake the person. Shout their name and rub firmly on the center of their chest. Signs of an opioid overdose can include slow or stopped breathing, blue or gray lips or fingertips, pinpoint pupils, and being unresponsive.
  2. Call 911. Say the person is not breathing or will not wake up.
  3. Lay the person on their back, insert the nozzle into one nostril, and press the plunger fully.
  4. If they do not respond within 2 to 3 minutes, give a second dose in the other nostril with a new device.
  5. If they are breathing, roll them onto their side. Stay with them until emergency responders arrive, even if they wake up.

Naloxone works only on opioids. It will not reverse an overdose caused by alcohol, benzodiazepines, or stimulants alone. But because fentanyl contamination is so common, and because naloxone is not expected to harm someone who has no opioids in their system, responders are generally advised to give it whenever an opioid overdose is possible. California also has a Good Samaritan law that offers some legal protections to people who call for help during an overdose. The protections have limits, but the guidance from public health agencies is consistent: call.

A Related Safety Note on Alcohol and Benzodiazepines

Some people leave residential treatment while still tapering a benzodiazepine, or with a history of heavy alcohol use. Withdrawal from alcohol and from benzodiazepines can cause seizures and can be life-threatening. Never stop either one abruptly after discharge without guidance, and never try to manage that withdrawal at home on your own. If the medication plan changes or a return to drinking happens, the next step is medical supervision, not a home taper.

The Household Check to Run Your First Night Home

This takes about ten minutes, and it is the single most useful thing a family can do on day one:

  1. Count the doses. Confirm there are at least two, and read the expiration date out loud.
  2. Agree on the spot. Put the naloxone in its fixed location while everyone is watching.
  3. Hand it around. Each adult in the house should hold the device and read the package directions once. Practice the motion without pressing the plunger.
  4. Say the sequence. Out loud: “Shout and rub, call 911, spray, wait 2 to 3 minutes, second spray, side position, stay.”
  5. Set the reminder. Put the expiration date in a phone calendar for every adult in the home.

The point is not to dwell on the worst case. It is to make the response automatic.

Questions to Ask Before Discharge

If you or a family member is in residential treatment now, bring these questions to the next discharge-planning meeting: Will the program provide naloxone or send a prescription to my pharmacy? Can a family member attend a short training before I leave? Does my aftercare plan include a clinician I can call if I return to use? Our treatment consultants can help families think through these questions. Call (877) 328-1968 to talk with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always follow the directions on your naloxone package and the guidance of your health care provider. If someone is unresponsive or not breathing, call 911 immediately. If you or someone you know is in crisis, call or text 988 to reach the 988 Suicide and Crisis Lifeline.

/by

Benzodiazepine Tapering in Residential Treatment: How the Schedule Is Set and What to Confirm Before Admission

, , ,
Prescription bottle with pills on a counter — residential rehab for chronic pain and opioid use disorder

When someone calls our admissions line about alcohol or opioids, a benzodiazepine prescription often comes up almost as an afterthought: “I also take Xanax for sleep,” or “My doctor has had me on clonazepam for years.” That detail changes the admission plan more than almost anything else on the intake form. Benzodiazepines cannot be stopped the way many people expect, and the schedule for coming off them is set by clinical guidance, not by how long a residential stay happens to last.

This post walks through how a benzodiazepine taper is actually planned in residential treatment, what the published guidance says about pace, and what you should confirm with a program before you arrive.

Why Benzodiazepines Are Handled Differently at Admission

Benzodiazepines, including alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium), act on the brain’s GABA system. With daily use over weeks or months, the brain adapts. Remove the medication suddenly and that adaptation is left unopposed.

Safety first: stopping a benzodiazepine abruptly after regular use can cause withdrawal seizures, which can be life-threatening. The same is true of alcohol. Anyone who has been using benzodiazepines or alcohol daily should not stop on their own, cut down sharply before a bed opens, or “detox at home” without medical supervision. If you are in that situation now, call us at (877) 328-1968 before changing anything.

The mechanism matters because it explains why programs ask so many questions on the first call. In our admissions work, the families who are most surprised are those whose loved one was prescribed the medication legitimately. Dependence is a physical adaptation, and it can develop whether the prescription was followed exactly or not. The National Institute on Drug Abuse describes this distinction between physical dependence and addiction in its overview of prescription medicine misuse.

What the Published Guidance Says About Taper Pace

In 2025, the American Society of Addiction Medicine and a group of partner medical societies released a joint clinical practice guideline on benzodiazepine tapering. It is the reference point most clinicians now use, and it is the document worth asking a program about by name.

A benzodiazepine taper for someone with long-term daily use is usually measured in weeks to months, not days. The joint clinical practice guideline on benzodiazepine tapering, published in 2025 by the American Society of Addiction Medicine and partner medical societies, describes a typical starting pace of dose reductions of about 5 to 10 percent every 2 to 4 weeks, and generally advises against reductions larger than 25 percent in any 2-week period. That means a person entering a 30- to 45-day residential program on a daily benzodiazepine will often still be tapering at discharge, and the discharge plan needs a named prescriber to continue the schedule.

Pace is individualized. The guideline describes adjusting speed based on how the person tolerates each step, and pausing when symptoms are significant. Some people move faster under close supervision; some need much longer. You can read the guideline summary through ASAM’s clinical guidelines page.

The U.S. Food and Drug Administration added a boxed warning to all benzodiazepines in 2020 covering misuse, dependence, and withdrawal reactions, including the risk of abrupt discontinuation. That warning is one reason prescribers have become more cautious about both starting and stopping these medications quickly.

What Drives the Taper Schedule

When our clinical team builds a taper plan, these are the factors that shape it:

  • Duration of use: months or years of daily use generally call for a slower taper than a few weeks of use.
  • Dose and drug: short-acting drugs like alprazolam can produce sharper swings between doses than longer-acting ones, which is why some prescribers convert to a longer-acting benzodiazepine before reducing.
  • Alcohol or other sedatives: combined use of alcohol and benzodiazepines raises withdrawal risk and requires more intensive medical monitoring.
  • Seizure history: any prior withdrawal seizure moves the plan toward a slower, more closely supervised schedule.
  • Co-occurring anxiety or insomnia: the original reason for the prescription does not go away during a taper, so it needs its own treatment plan, often therapy-based.
  • Opioid use or medication for opioid use disorder: the combination of opioids and benzodiazepines increases overdose risk, and coordination between prescribers is essential. The CDC addresses this risk in its overdose prevention resources.

What the First Weeks Actually Look Like

People expect withdrawal to feel like a single hard week. With a properly paced taper, it is usually quieter and longer than that. In the early reductions, clients commonly describe rebound anxiety, lighter or broken sleep, irritability, and a sense of being “on edge” in the evening. Some notice sensitivity to light or sound. Families on visiting days often say their loved one seems more anxious than before treatment, and they worry the program is not working.

That is often what a taper feels like when it is working. The nervous system is readjusting step by step, and each reduction is followed by a period of settling before the next one. This is where residential care earns its place: nursing staff can watch vital signs and symptoms daily, the prescriber can hold a step if needed, and the person is learning non-medication tools for anxiety and sleep in real time, during the exact hours when the old medication used to do that job.

The inconvenient truth from the admissions side is that the hardest conversation is often not about the drug at all. It is telling someone that their benzodiazepine taper will likely continue after they leave our residential program, and that the most important document they take home may be the outpatient prescriber’s appointment, not the discharge summary.

Five Things to Confirm Before Admission

If you or a family member takes a benzodiazepine daily, ask these questions on the admissions call. Write down the answers.

  1. Who manages the taper? Ask for the role of the person who will set and adjust the schedule, such as a physician or psychiatric nurse practitioner, and how often they see clients.
  2. Is the program medically equipped for sedative withdrawal? Ask what level of medical monitoring is available on site and what happens if symptoms escalate. Our residential treatment page explains how care is structured.
  3. Bring every prescription bottle. Bring the actual bottles, with current labels, plus the name and phone number of the prescribing doctor. Today, check the label: write down the drug name, dose, and how many tablets are taken each day. That single list speeds up the medical assessment.
  4. What happens to the taper at discharge? Ask whether the program coordinates a hand-off to an outpatient prescriber and whether that appointment is booked before you leave.
  5. What does insurance cover? Medically monitored withdrawal management may be billed differently than residential care. You can start with a confidential insurance verification.

Do not reduce your dose in the days before admission to “get a head start.” A sudden cut while you wait for a bed is exactly the kind of change that carries seizure risk.

How We Approach This at Bodhi

At Bodhi Addiction Treatment in Northern California, benzodiazepine tapers are planned individually, with medical oversight and a discharge plan that names who continues the schedule. Our clinical approach reflects the practice experience of our founder, Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, and our team’s work with clients managing both substance use and the anxiety that often came before it.

If you are unsure whether a current prescription affects your admission, the fastest step is to ask. Call (877) 328-1968 and have the prescription label in front of you. If you need help finding treatment anywhere in the country, SAMHSA’s National Helpline is free, confidential, and available 24 hours a day at 1-800-662-4357. If you are in crisis or thinking about harming yourself, call or text 988.

This article is for educational purposes only and is not medical advice. Do not start, stop, or change the dose of any medication without guidance from a qualified healthcare provider. Benzodiazepine and alcohol withdrawal can be dangerous and require medical supervision. If you are experiencing a medical emergency, call 911.

/by

Paying for Residential Treatment Without Insurance: The Good Faith Estimate, the $400 Dispute Rule, and What to Get in Writing

, ,
Clinician consulting a person with cocaine induced psychosis in residential stabilization

Families who call us about paying for residential treatment out of pocket usually have one number in front of them: the weekly or monthly rate a program quoted on the phone. In our placement work, that number is rarely the number on the final bill. The gap is not always bad faith. It is usually the difference between what the program considers “the program” and what the family assumed was included. This guide explains the federal protections that apply when you pay without insurance, the line items that most often fall outside a quote, and exactly what to ask for in writing before admission.

The Good Faith Estimate: The Federal Right Most Self-Pay Families Never Use

Under the federal No Surprises Act, in effect since January 1, 2022, a person who is uninsured or chooses not to use insurance for residential addiction treatment has the right to a written Good Faith Estimate of expected charges before care begins. When the stay is scheduled at least three business days ahead, the provider must deliver the estimate within one business day of scheduling; when it is scheduled ten or more business days ahead, within three business days. If the final bill from a provider or facility comes in at least $400 above its estimate, the patient can start a federal patient-provider dispute within 120 calendar days of the date on that bill. The Centers for Medicare & Medicaid Services explains these rights on its No Surprises Act consumer page.

Two practical points matter here. First, you can ask for the estimate even before you have a date, and you should ask in writing so there is a record of the request. Second, the estimate is only as useful as its line items. A single figure labeled “30-day program” tells you very little about what will be billed separately. If a program tells you the rule does not apply to them, ask them to explain why in an email. A licensed program that is confident in its pricing will not mind putting it on paper.

Why Self-Pay Bills End Up Higher Than the Quote

When we review quotes side by side for families, the same handful of causes accounts for nearly every surprise. None of them require anyone to be dishonest. They come from vague language at the front door.

  • Detox billed as a separate level of care: Many residential programs quote the residential rate only, and medically monitored withdrawal management is priced and sometimes delivered by a different provider.
  • Psychiatry outside the daily rate: A psychiatric evaluation and follow-up medication management visits are often billed by an independent prescriber rather than the facility.
  • Medications and lab work passed through: Prescriptions, drug screens, and blood work may be billed at cost or by an outside pharmacy or laboratory.
  • Off-site medical care: An urgent care visit, dental emergency, or hospital trip during the stay is almost never included in a program rate.
  • Deposits and refund terms nobody read: A nonrefundable deposit or a “no refund after day seven” clause matters a great deal, because the urge to leave early is common in the first week of treatment.

Each of these is a fair business practice on its own. The problem is that families compare a residential-only quote from one program against an all-inclusive quote from another and pick the wrong one as the “cheaper” option.

What “All-Inclusive” Should Mean in Writing

“All-inclusive” is a marketing phrase, not a contract term. Before you sign anything, ask the admissions coordinator to list, item by item, what the quoted rate covers. A complete answer should address room and board, individual therapy sessions per week, group programming, family sessions, case management, medical monitoring during withdrawal, psychiatric care, medications, drug testing, lab work, transportation, and discharge planning. If something is excluded, the quote should say who bills for it and roughly what it costs.

It also helps to know which level of care you are actually buying. The ASAM Criteria, the framework most programs use to match people to care, distinguishes clinically managed residential services from medically monitored and medically managed services. Those differ in staffing and in what they can safely handle, and they are priced differently. Our overview of residential treatment walks through what each setting typically provides.

A Safety Note Before Anyone Tries to Save on Detox

We sometimes hear from families who plan to have their loved one “get through withdrawal at home” so they only pay for the residential portion. For alcohol and benzodiazepines, that plan can be dangerous. Withdrawal from either can cause seizures and, with alcohol, delirium tremens, both of which can be life-threatening. Medical supervision is required for anyone who has been drinking heavily and daily or taking benzodiazepines regularly, and benzodiazepines should never be stopped abruptly without a prescriber directing a taper. The National Institute on Alcohol Abuse and Alcoholism publishes clinical guidance on why alcohol withdrawal needs to be medically assessed. If the quote does not include withdrawal management, the answer is to price it properly, not to skip it.

The Email to Send Before You Pay a Deposit

This is the step we ask every self-pay family to take today, before any money changes hands. Copy the questions below into an email to the program’s admissions or billing contact and keep the reply.

  1. Please send a written Good Faith Estimate for a stay of [number] days, with each expected charge listed separately.
  2. Which of these are billed by your facility, and which are billed by outside providers (psychiatry, pharmacy, laboratory, medical detox)? Please give estimated amounts for each.
  3. What is your state license number, and which level of care is this stay licensed to provide?
  4. How much is the deposit, is any of it refundable, and what is the refund policy if the stay ends early for any reason?
  5. Who confirms the discharge plan, and is aftercare scheduling included in the rate?

If the answers come back incomplete, that tells you something too. In our experience, programs that answer all five clearly are the same programs that communicate well with families during the stay. If you would like help reading a quote, our team can review it with you at no cost. Call (877) 328-1968 or request a treatment consultation.

Check Your Coverage Before Assuming You Are Self-Pay

Many people who start out planning to pay privately have more coverage than they think. Federal parity law generally requires most health plans that cover substance use disorder treatment to do so on terms comparable to medical and surgical care, and California law adds its own medical necessity requirements for plans it regulates. A denial or an out-of-network plan is not always the end of the conversation. Before committing to a full private-pay rate, it is worth a free insurance verification so you know which parts of the stay might be covered and which truly will be out of pocket.

If cost is the barrier that is stopping someone from getting care at all, the SAMHSA National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day, and it can point families toward state-funded and sliding-scale options. FindTreatment.gov, also run by SAMHSA, lets you filter licensed programs by payment type.

Why Getting This Right Matters for the Outcome

Money conversations feel separate from clinical ones, but they are not. Research summarized by the National Institute on Drug Abuse emphasizes that staying in treatment for an adequate period matters. A family that runs out of funds on day 18 of a planned 30-day stay, because detox and psychiatry were billed on top, faces a hard choice at exactly the wrong moment. A clear estimate up front lets you plan the full course, including the step-down to outpatient care, instead of discovering the shortfall mid-stay.

Bodhi Addiction Treatment helps individuals and families across Northern California compare residential options, understand what a quote covers, and plan the stay from admission through discharge. If you are weighing private pay, call (877) 328-1968 and we will walk through the numbers with you.

This article is for educational purposes only and is not medical, legal, or financial advice. Billing rules can change and may apply differently depending on the provider and your coverage; confirm details with the program, your plan, or a qualified advisor. If you or someone you love is in crisis, call or text 988 for the 988 Suicide & Crisis Lifeline, or call 911 in an emergency.

/by

How to Vet a Residential Treatment Program in California: License, Level of Care, and the Questions to Ask Before Admission

, , ,
alcohol detox retreat

Most families find a residential program the same way: a late-night search, a polished website, and a phone call to an admissions line that answers on the first ring. Within an hour, someone is offering a bed for tomorrow. That speed can feel like relief. It can also be the moment a family commits to a program it has not checked at all.

At Bodhi, our work is placing people into residential, PHP, and outpatient programs, which means we vet programs for a living. This guide lays out the checks we run, in the order we run them, so you can do the same before anyone packs a bag. If you would rather have us run them with you, call (877) 328-1968.

The Short Version: What to Verify Before Admission

Before committing to a residential drug or alcohol program in California, a family should confirm five things in writing: that the facility holds a current residential license from the California Department of Health Care Services (DHCS) for the address where the person will actually sleep; which ASAM level of care the program delivers, such as 3.5 or 3.7; who manages withdrawal and what happens if symptoms escalate overnight; how the program bills your specific insurance plan; and what the discharge plan will include. If a program cannot answer all five clearly on one phone call, keep looking. SAMHSA’s National Helpline, 1-800-662-4357, is free, confidential, and open 24 hours a day, 365 days a year, and can point you toward licensed options if you are starting from nothing.

Step One: Confirm the License Matches the Address

In California, residential addiction treatment programs are licensed by DHCS, and the license is tied to a specific facility address. A program’s website may list one headquarters while clients actually sleep in a separate house across town. What you want to know is whether that house is licensed for residential treatment.

Ask the admissions coordinator for the facility’s DHCS license number and the street address it covers, then check it against the state’s public licensed-facility listing. This takes about ten minutes. In our placement work, the gap we run into most is not an unlicensed program, but a licensed program whose overflow beds sit at an address that is not on the license. That is a question worth asking directly: “Will my family member sleep at the licensed address for the entire stay?”

Accreditation from bodies such as The Joint Commission or CARF is a useful additional signal, but it does not replace the state license.

Step Two: Ask Which ASAM Level of Care They Provide

“Residential” covers a wide range. The American Society of Addiction Medicine (ASAM) Criteria divide residential care into levels with different staffing and medical capability. In broad terms, Level 3.1 is a lower-intensity, clinically managed setting; Level 3.5 is a clinically managed, high-intensity program for people who need a structured 24-hour environment; and Level 3.7 adds medical monitoring, with nursing and physician involvement available around the clock.

Why this matters in practice: a person who needs 3.7-level medical monitoring placed into a 3.1 setting is a safety problem, and a person placed far above their needs may face insurance pushback. Our residential treatment overview explains how these levels fit with step-down care. If you are unsure which level fits, a level-of-care assessment should come before the admission, not after.

Step Three: Pin Down Who Handles Withdrawal

This is the question we press hardest, because it is where the consequences are most serious. Alcohol and benzodiazepine withdrawal can cause seizures and can be life-threatening, and they require medical supervision. Alcohol withdrawal symptoms commonly begin within about 6 to 24 hours after the last drink, which means the first night at a facility can be the riskiest one.

Ask these questions word for word:

  • “Is withdrawal management done on-site, and is the facility licensed or certified for that service?”
  • “Is there a nurse awake in the building overnight?”
  • “Who decides when someone needs to be transferred to a hospital, and how fast does that happen?”
  • “If detox happens somewhere else first, who coordinates the handoff and on what day?”

A strong program answers these without hesitation. A weak answer sounds like “our staff is trained to handle it” without naming who is on shift at 2 a.m.

Step Four: Get the Insurance Answer in Writing

“We take your insurance” is not the same as “we are in-network with your specific plan and have verified your residential benefit.” Ask for the verification of benefits in writing: deductible remaining, out-of-pocket maximum, whether prior authorization is required, and how many days are authorized at the start. Initial authorizations are often shorter than families expect and are reviewed as treatment goes on.

You can run a check through our insurance verification page before choosing a program, which gives you a baseline to compare against what admissions tells you.

Warning Signs We See in Placement Work

Over years of placing California families, a handful of patterns have reliably predicted a poor experience. None of them proves wrongdoing on its own, but each one is a reason to slow down.

  • Free travel or cash incentives: California law (SB 1228, signed in 2018) prohibits licensed treatment providers from paying or receiving anything of value for patient referrals, so offers of free flights or gift cards to enroll are a serious red flag.
  • Pressure to decide within the hour: urgency is real when someone is in crisis, but a legitimate program will still give you the license number and a written benefits summary before you commit.
  • Vague clinical staffing: if no one can tell you the credentials of the therapists or the name of the medical director, the clinical program may be thinner than the website suggests.
  • Silence about discharge: programs that never mention aftercare tend to treat the stay as the whole plan, when recovery planning should begin early in the stay.
  • Refusal to involve family at all: privacy rules limit what a program can share without consent, but a good program will explain how consent works and how family sessions are scheduled.

What Families Actually Notice in the First Week

Families often tell us the first sign a program is right is boring logistics working smoothly: the call back that comes when promised, the medication list that gets reconciled on day one, the counselor who learns the person’s name before the intake paperwork is finished. The first sign a program is wrong is usually the opposite: calls that go unanswered, a different story each time about when the doctor will see your family member, or confusion about who is responsible for what.

For the person in treatment, week one is often physically and emotionally rough regardless of program quality. Sleep is broken, irritability runs high, and the urge to leave can be strong. That is expected. What should not be happening is uncertainty about basic safety, medication, or whether anyone is paying attention.

Why Evidence-Based Care Is the Baseline

The National Institute on Drug Abuse’s principles of effective treatment emphasize that no single treatment is right for everyone, that staying in treatment long enough matters, and that care should address the whole person, including co-occurring mental health conditions. Ask any program how it handles depression, anxiety, or trauma alongside substance use, and whether it supports medications for alcohol or opioid use disorder when clinically appropriate. A program that dismisses FDA-approved medications outright is narrowing your options before an assessment has even been done.

For alcohol use disorder specifically, the NIAAA Alcohol Treatment Navigator offers free guidance on questions to ask providers, which pairs well with the steps above. SAMHSA’s National Helpline is another neutral starting point.

Do This Today: The Ten-Minute Phone Check

Before you agree to an admission date, call the program and ask for three things in a single call: the DHCS license number and the address it covers, the ASAM level of care they will provide, and the name or role of the person who manages withdrawal overnight. Write down the answers and who gave them. Then compare the license against the state listing. If any of the three is missing, or changes on a second call, treat it as a no.

If you want a second set of eyes, our treatment consulting team can walk through the answers with you and suggest vetted programs that fit the level of care your family member needs. Call (877) 328-1968 to talk it through.

If someone is in immediate danger, call 911. If you or someone you love is in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can be dangerous and should only happen under medical supervision. Always consult a qualified healthcare provider about your specific situation.

/by

Why the Treatment Center Won’t Give You Updates: Consent Forms, 42 CFR Part 2, and What Families Can Do

, ,
how couples rehab program works when both partners enter residential together - two people walking a redwood forest path in early recovery

A parent calls a residential program two days after dropping their son off. They ask how he is doing. The person on the phone says, politely, that they cannot confirm whether anyone by that name is a patient. The parent hangs up frightened and angry, convinced something has gone wrong. Nothing has. What they ran into is a federal confidentiality rule and a consent form that was either never signed or does not name them.

Here is how that process works, what the consent form controls, and the steps families can take on admission day so the first week is not also a week of silence.

The Short Answer: 42 CFR Part 2 and the Signed Consent

In the United States, the confidentiality of substance use disorder treatment records from federally assisted programs is governed by a federal regulation known as 42 CFR Part 2, which has been in place since the 1970s and was updated in 2024 to align more closely with HIPAA. Under Part 2, a treatment program generally cannot disclose information that identifies someone as a patient, including simply confirming that the person is admitted, unless that patient has signed a written consent naming who may receive the information. For families, this means the consent form signed at admission, not the family relationship, determines whether staff can speak with you. A spouse, parent, or adult child with no signed consent on file will usually be told that staff can neither confirm nor deny that the person is there.

The full text of the regulation is published in the Electronic Code of Federal Regulations. The Substance Abuse and Mental Health Services Administration (SAMHSA) is the federal agency that oversees Part 2 and publishes guidance on it for programs and patients.

Why the Phone Goes Quiet in Week One

Silence usually has an administrative cause:

  • No consent on file: The patient was too sick, too anxious, or too ambivalent on admission day to sign a release, and nobody went back to it.
  • A consent that names someone else: The release lists one parent, and the other parent is the one calling.
  • A narrow scope: The form allows staff to confirm attendance but not to discuss clinical progress, medications, or discharge planning.
  • A revoked consent: Patients can revoke consent, and some do during a hard stretch of withdrawal or an argument on the phone, then sign again days later.
  • A clinical blackout period: Some programs limit outside calls for the first several days so a person can stabilize. That is a program policy, separate from the consent, and it should be explained to you at admission.

From where I sit, the inconvenient truth is that the consent form is usually signed on the day a person is least able to think clearly about it. Someone arriving in early withdrawal, or after a night of heavy use, signs a stack of intake paperwork quickly. The release of information is one page in that stack, and it is often narrower than the family assumes. When families plan for this page in advance, the first week goes very differently.

What a Valid Consent Form Usually Includes

Part 2 sets out required elements for a written consent. Forms vary by program, but a consent that will actually let staff speak with you typically states:

  • The patient’s name.
  • The name of the person or organization allowed to receive information, such as “Jane Doe, mother.”
  • How much and what kind of information may be shared, for example attendance only, or general progress and discharge planning.
  • The purpose of the disclosure, such as family involvement in treatment.
  • A statement that the patient may revoke the consent.
  • An expiration date, event, or condition.
  • The patient’s signature and the date.

If you are not named on the form, staff generally cannot make an exception because you are family or because you are paying for treatment. Payment and consent are separate questions.

What to Do on Admission Day: A Five-Step Checklist

These are steps you can take today, before or during admission:

  1. Talk about the consent before you arrive. In the car or the night before, ask your loved one directly: “Will you sign a release so I can talk to your counselor?” Agreeing in a calm moment makes the signature on admission day much more likely.
  2. Ask admissions for the release by name. Say, “Before I leave, can we complete the release of information form for me?” Do not assume it happened with the rest of the paperwork.
  3. Write down exactly whose names are on it. If two parents, a spouse, and a sibling all expect updates, each needs to be named, or the form needs to name one family contact who relays information.
  4. Ask what the scope covers. Confirm whether staff can discuss attendance, general progress, family sessions, and discharge planning, and whether it includes the case manager as well as the therapist.
  5. Ask about the program’s call and visit policy. Get the dates for any blackout period and the name of the person you should call first, so you know when silence is expected and when it is not.

If you are still deciding on a program, our admissions team can walk you through intake paperwork before the day itself. Call (877) 328-1968 and ask how releases of information are handled during our residential treatment intake.

What Staff Can Still Do Without a Consent

Confidentiality rules protect the patient, but they do not stop the program from listening to you. Even without a consent on file, staff can usually take your call and accept information. If you know something clinically important, such as how much your loved one was drinking or a history of seizures, say it. Staff may not be able to respond, but they can document it.

Part 2 also allows disclosure without consent in a bona fide medical emergency. If your loved one is in danger, emergency care is not blocked by the paperwork.

Where a person has left treatment early during detox, the safety picture matters more than the paperwork. Withdrawal from alcohol or benzodiazepines can cause seizures and other serious complications, and it requires medical supervision. If someone has left treatment during alcohol or benzodiazepine withdrawal and is showing confusion, tremors, hallucinations, or seizure activity, call 911. If you are worried about suicide, call or text 988, the Suicide and Crisis Lifeline.

When a Loved One Refuses to Sign

Some patients decline to sign a release, and that is their legal right as an adult. It is painful, and it is common early on. Refusal is often about shame or a strained relationship rather than a plan to hide something.

A few things tend to help:

  • Ask the counselor to raise the release again after the first several days, when the person is more stable.
  • Offer a narrower release. “Attendance only” or “discharge date only” is easier to agree to than full clinical access.
  • Ask about family therapy. Family sessions give the patient some control over what is discussed and often lead to a broader consent over time.
  • Get support for yourself. The SAMHSA National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day, 365 days a year, and can point families toward local support.

The National Institute on Drug Abuse (NIDA) describes addiction as a treatable, chronic condition, and family involvement is widely recognized as one of the supports that can help people stay engaged in care. A release of information is one practical route into that involvement.

Consent at Discharge

The consent question comes back at the end of a stay. Aftercare often involves an outpatient program, a physician, a therapist, and sometimes an employer or a court. Each may need its own release. Before discharge, ask the case manager which releases are active, which expire at discharge, and which the patient needs to sign for the next provider. Our case management team handles this as part of discharge planning, so the next provider receives what it needs without a gap.

Questions to Ask at Your Next Call

If you are already in the middle of a stay and feel shut out, call the program and ask these three questions:

  1. “Is there an active signed release of information naming me?”
  2. “If there is, what does it allow you to discuss?”
  3. “If there is not, can you let my loved one’s counselor know I would like to be named on a release?”

To talk through admissions, consent paperwork, or family involvement in treatment in Northern California, call Bodhi Addiction Treatment at (877) 328-1968.

This article is for educational purposes only and is not legal or medical advice. Confidentiality rules can vary by program type and state, and programs apply them to individual circumstances. For questions about a specific situation, speak with the treatment program directly or with a qualified attorney. If you or someone you love is in immediate danger, call 911. For a mental health crisis, call or text 988.

/by

The Discharge Plan From Residential Treatment: What Should Be Confirmed Before You Leave

,
Beach Overhead

The last week of a residential stay moves faster than most people expect. The daily structure is still in place, but the conversations shift from what happened to what happens next. The document that holds those answers is the discharge plan, sometimes called the continuing care or aftercare plan. A good one is specific enough that someone could follow it on a bad day without having to make a single new decision. A weak one is a list of good intentions.

This guide walks through what a residential discharge plan should contain, what to confirm before you walk out the door, and the questions families can ask on the final days. It is written for people currently in residential treatment, the family members supporting them, and anyone comparing programs who wants to know what should happen at the end of a stay, not only the beginning.

What a Residential Discharge Plan Is

A residential discharge plan is a written document, prepared by the clinical team with the client before they leave, that names the next level of care, the first appointment date and time, current medications and who will prescribe them, the living arrangement, the support contacts, and the specific steps to take if cravings, a return to use, or a mental health crisis occurs. In our experience, the single most useful test of a discharge plan is whether the first outpatient appointment is booked with a date and time before discharge day, ideally within seven days of leaving, rather than written as a referral to “follow up with outpatient care.”

That distinction matters because the days immediately after residential care are when the structure disappears all at once. Meals, schedules, group sessions, and the people who noticed small changes in mood are no longer there by default. The plan is what replaces them.

Why the Step-Down Matters as Much as the Stay

Residential treatment is one level of care, not the whole course of treatment. The National Institute on Drug Abuse (NIDA) Principles of Drug Addiction Treatment note that most people need at least three months of treatment to significantly reduce or stop drug use, and that longer engagement is associated with better outcomes. Many residential stays are shorter than that, which means the treatment that follows is not optional extra support. It is the rest of the treatment.

Clinicians typically use the American Society of Addiction Medicine (ASAM) Criteria to decide which level of care comes next. For many people, that is a partial hospitalization program (PHP), which usually runs most of the day on weekdays, or an intensive outpatient program, which typically meets several times per week for a few hours. The right step-down depends on how stable the person is medically and psychiatrically, how supportive the home environment is, and how strong cravings still feel.

What Goes Wrong: The Common Gaps

When we review discharge plans that did not hold up, the problems are rarely dramatic. They tend to be small logistical gaps that become large on day three at home.

  • Referral without an appointment: A phone number for an outpatient program is not the same as a confirmed start date, and waiting lists can run longer than expected.
  • Medication gap: Prescriptions started in residential care can lapse if no outpatient prescriber has agreed to continue them before discharge.
  • Insurance authorization lag: The next level of care may need its own authorization, and a denial or delay discovered after discharge leaves days with no treatment in place.
  • Unchanged home environment: Returning to a home with alcohol in the cupboard or old contacts saved in the phone puts cues back in front of someone who has just learned to manage them.
  • Lost tolerance: After weeks without opioids, the body’s tolerance drops, and a return to a previously used amount can cause a fatal overdose.

The last item is a safety issue, not a planning detail. Anyone leaving residential treatment after opioid use should leave with naloxone and with the people they live with knowing where it is and how to use it.

The Discharge Plan Checklist: What to Confirm Before You Leave

This is the check to run in the last few days of a stay. Each item should have a name, a date, or a phone number next to it, not a general intention.

  1. Next level of care: Which program, which address or virtual link, and the date and time of the first session.
  2. Insurance status: Whether the next level of care has been authorized, and who to call if the authorization is still pending.
  3. Medications: A written list of every current medication and dose, who is prescribing each one after discharge, when the first prescriber appointment is, and how many days of supply you are leaving with.
  4. Therapy and psychiatry: Named clinicians and first appointment dates for individual therapy and, if relevant, psychiatric follow-up for co-occurring conditions.
  5. Living arrangement: Where you will sleep on the first night, and whether the home has been cleared of alcohol and drugs, or whether sober living is the safer option.
  6. Support contacts: At least three people you can call, with at least one who is available in the evening, plus a recovery meeting or peer group you plan to attend in the first week.
  7. Warning signs: Your own early warning signs, written in your own words, and what you will do when you notice them.
  8. Return-to-use plan: Who you will call first, and how to get back into care the same day rather than waiting until the next scheduled appointment.

If any line on that list is blank on discharge day, ask the team to fill it in before you leave. Our case management staff can help coordinate appointments and paperwork, and you can reach our admissions and clinical team at (877) 328-1968 with questions about what the step-down should look like.

Medical Safety After Discharge

A return to use after residential treatment is common and does not mean treatment failed. Addiction is a chronic condition, and relapse is a signal to adjust the plan, not abandon it. But some returns to use carry specific medical risks that the discharge plan needs to name directly.

Alcohol and benzodiazepines: If someone resumes heavy drinking or benzodiazepine use and then tries to stop suddenly on their own, withdrawal can cause seizures and can be life-threatening. Stopping after renewed heavy use of either substance requires medical supervision. Do not attempt it at home without a physician involved.

Opioids: Reduced tolerance after a residential stay sharply raises the risk of overdose. Keep naloxone in the home, make sure household members know how to use it, and call 911 if someone is unresponsive or breathing slowly.

Mental health: If you or someone you love is having thoughts of suicide or is in emotional crisis, call or text 988 to reach the 988 Suicide and Crisis Lifeline, or call 911 in an emergency.

Questions Families Can Ask in the Final Week

Family members often want to help but are unsure how involved to be. With the client’s consent, it is reasonable to ask the clinical team the following at a family session or discharge meeting:

  • What level of care is recommended next, and why that level rather than a higher or lower one?
  • Is the first appointment booked, and on what date?
  • Which medications are being continued, and who is writing the prescriptions after discharge?
  • What changes should we make at home before our family member returns?
  • What should we do, and who should we call, if we notice warning signs?

Families do not need to monitor or manage the plan. Their most useful role is usually knowing what the plan says, removing obvious obstacles at home, and knowing the number to call if things change.

If You Leave Without a Plan

Sometimes people leave residential care earlier than recommended or without a finished plan. If that has happened, the plan can still be built. Call the program you left and ask for a referral to the next level of care, contact your insurer to confirm which programs are in network, and reach out to the SAMHSA National Helpline at 1-800-662-4357, a free, confidential, 24-hour treatment referral and information service. You can also call our team at (877) 328-1968 to talk through options, including re-entering care.

The purpose of a discharge plan is not to predict every problem. It is to make sure that when a hard day arrives, the next step is already written down and the phone numbers are already in hand.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified health provider with questions about a medical or mental health condition. If you are experiencing a medical emergency, call 911. If you are in crisis, call or text 988.

/by

Admission Day for Residential Treatment: What to Bring, What to Leave, and Why the Last Drink Matters

, , ,
Santa Cruz Outpatient Addiction Therapy Program

Most families call us about packing the night before admission. By then the question is rarely “what clothes should I bring?” It is usually “she drank until midnight — is that a problem?” or “he stopped his Xanax on his own so he could arrive clean.” After years of placing Northern California families into residential programs, I can say the suitcase is the easy part. What actually decides how smoothly admission day goes is paperwork, medications, and an honest account of the last drink or dose.

This guide walks through admission day for residential treatment in the order it actually happens, with a checklist you can complete today. If you have not yet confirmed coverage, start with our insurance verification page or call (877) 328-1968 before you pack anything.

Do Not Stop Drinking or Taking Benzodiazepines on Your Own Before Admission

People entering residential treatment for alcohol or benzodiazepine use should not quit abruptly on their own in the days before admission, even to “show up sober.” Alcohol withdrawal symptoms commonly begin within 6 to 24 hours of the last drink, which means a person who stops the night before can be entering the most unpredictable stretch of withdrawal while sitting in a car on the way to intake. Alcohol and benzodiazepine withdrawal can cause seizures and, in severe cases, delirium; both require medical supervision. The safer approach is to keep use steady and unchanged as instructed by the admissions team, then report the exact time and amount of the last use at intake so the medical staff can plan detox from accurate information.

That paragraph is the single most important thing in this article. The American Society of Addiction Medicine’s alcohol withdrawal management guideline treats withdrawal as a medical process to be assessed and monitored, not an endurance test. In practice, the families I work with who arrive with a clear, honest timeline get settled faster, because the nursing team is not guessing.

If you or someone you love is already in withdrawal and shows confusion, hallucinations, a seizure, or a racing heart with heavy sweating, call 911. Do not wait for the admission date.

Why Admission Day Goes Wrong: The Four Usual Causes

Most delayed or rocky admissions trace back to a short list of avoidable problems:

  • Missing medication information: Without pharmacy-labeled bottles or a printed list, the medical team may not be able to continue a prescription until it is confirmed with the prescriber.
  • An inaccurate use history: Understating the amount or recency of use is common and human, but it can lead to withdrawal being under-treated in the first 48 hours.
  • Unresolved insurance questions: A benefits check that was never completed, or an authorization still pending, can hold up admission paperwork on arrival.
  • Prohibited items in the bag: Anything containing alcohol, unapproved supplements, or sealed items that cannot be inspected adds time to the intake search and sometimes a difficult conversation.

None of these are character problems. They are logistics, and every one of them can be handled the day before.

The Documents Folder: What to Bring

Put these in a single folder or large envelope, not scattered through luggage:

  • A government-issued photo ID.
  • Your insurance card (front and back copies are helpful too), plus the name of the policyholder if it is not you.
  • A printed list of every medication, the dose, the time you take it, and the prescriber’s name and phone number.
  • Contact information for anyone the program may speak with once you sign a release: a spouse, a parent, a therapist, a primary care doctor.
  • Any legal paperwork with dates attached, such as a court date, probation contact, or a medical leave form your employer needs completed.
  • A small amount of cash or a debit card for incidentals, if the program allows it.

Releases of information matter more than people expect. Federal confidentiality rules for substance use treatment records are strict, so staff generally cannot confirm to a family member that you have even arrived unless you have signed a release. Decide before admission who you want looped in.

The Medication Bag

Bring every current prescription in its original pharmacy-labeled bottle, including medications for blood pressure, diabetes, thyroid, mental health, and anything prescribed for sleep or anxiety. Do not consolidate pills into a pill organizer before arrival; staff need to see the label to verify it. The program’s medical team will review each one, may adjust some during detox, and will typically hold and dispense them. This includes over-the-counter products and supplements, which many programs restrict or need to approve.

If you take buprenorphine, methadone, or another medication for opioid use disorder, tell the admissions team before the admission date, not on arrival. The National Institute on Drug Abuse describes these medications as an evidence-based part of treatment, and a good residential program should have a plan to continue them rather than interrupt them.

The Suitcase: Clothing and Personal Items

Plan for about a week of comfortable clothing, since most residential programs have laundry access. Northern California weather swings a lot between morning and afternoon, especially near the coast, so layers work better than one heavy coat.

  • Comfortable daywear, sleepwear, and closed-toe shoes plus a pair of sneakers for walks or exercise.
  • A light jacket or sweatshirt and a warmer layer for evenings.
  • Toiletries that are alcohol-free and preferably new and sealed (many mouthwashes, hand sanitizers, and some hair products contain alcohol and are commonly restricted).
  • A notebook and pen, a few photos of people you love, and a book.
  • Reading glasses, a CPAP machine, hearing aid batteries, or any medical device you use daily.

Every program has its own contraband list, and they differ. Ask admissions to email you theirs, and pack against it line by line.

What to Leave at Home

Leave valuables, expensive jewelry, large amounts of cash, weapons of any kind, and anything containing alcohol. Vapes, energy drinks, and outside food are handled differently by different programs, so check the list rather than assume. On phones and laptops: many residential programs limit device use, especially during the first days, and some hold them entirely during detox. Before you leave, set up an out-of-office message, give one trusted person access to pay any bills that will come due, and write down the few phone numbers you will actually want.

What Happens in the First Few Hours

Admission day usually follows a predictable sequence: paperwork and consents, a search of belongings, a nursing assessment that includes vital signs and a substance use history, and often a drug screen. A physician or nurse practitioner typically reviews medications and decides whether withdrawal management is needed. Then comes a room assignment and a meal, and people are often surprised at how much of the first day is simply rest.

From the families I talk to afterward, the moment that sticks is rarely the search or the forms. It is the relief of not having to hold the plan together alone anymore. That relief is part of why the residential level of care works for people who have been unable to stop on their own.

Your Admission-Eve Checklist: Do These Five Things Today

  1. Call the admissions team and ask three direct questions: What should the last drink or dose look like before arrival? Can I have your contraband list in writing? Is my insurance authorization complete?
  2. Write down, on paper, the exact substances you use, the typical daily amount, and the time of your most recent use. Update it the morning of admission.
  3. Gather every prescription bottle into one bag and print a medication list with prescriber phone numbers.
  4. Decide who you will sign releases for, and write their names and numbers on a single card.
  5. Arrange a ride. Do not plan to drive yourself, particularly if you are drinking or may be entering withdrawal.

If you want help walking through this list for a specific program, our team does this every week. Call (877) 328-1968 and we can go through it with you, or read more about how we work on Jonathan Beazley’s profile. If you are not yet connected to a program, the SAMHSA National Helpline (1-800-662-4357) is free, confidential, and answers 24 hours a day, 365 days a year. For guidance specific to alcohol, the National Institute on Alcohol Abuse and Alcoholism is a reliable place to start.

If you are in crisis or thinking about harming yourself, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol and benzodiazepines can be dangerous and requires medical supervision. Always follow the instructions of your treatment program and a qualified medical provider. Program policies on medications, devices, and personal items vary.

/by

Insurance Denied Residential Treatment in California? The Appeal Timeline, SB 855, and Independent Medical Review

,
How to prepare emotionally for residential addiction treatment before admission - quiet redwood forest path

The call usually comes a day or two after admissions has lined everything up. The bed is held, the family has taken time off work, and then the insurance plan says no: residential treatment is “not medically necessary,” and outpatient care is recommended instead. For a family that has watched someone struggle for months, that letter can feel like a closed door. It usually is not. In California, a denial is the start of a defined process with deadlines on both sides, and families who know those deadlines are in a much stronger position.

This guide walks through what a residential treatment denial means, why it happens, and the appeal steps available under California law. If you would rather have someone walk through it with you, call Bodhi at (877) 328-1968.

The Short Version: California’s Appeal Timeline

In California, when a state-regulated health plan denies residential substance use treatment as not medically necessary, the member can file a grievance with the plan, which generally must resolve it within 30 days, or within 3 days when the situation involves an imminent and serious threat to the person’s health. If the plan upholds the denial, the member has up to 6 months from the plan’s decision to request a free Independent Medical Review (IMR) through the California Department of Managed Health Care, in which physicians who do not work for the plan decide whether the treatment must be covered.

Two details matter here. First, the IMR costs the member nothing. Second, an urgent case does not have to wait out the full 30-day grievance period. Rules and timelines can change, so confirm the current details on the Department of Managed Health Care website before you rely on any date.

Why California Law Changed the Conversation: SB 855

California’s mental health parity law, SB 855, took effect on January 1, 2021. It requires state-regulated commercial health plans and insurers to cover medically necessary treatment for mental health and substance use disorders, and it requires them to base those medical necessity decisions on generally accepted standards of care. For substance use disorders, that means criteria developed by nonprofit clinical specialty associations, most notably The ASAM Criteria from the American Society of Addiction Medicine.

In practical terms, a plan should not deny residential care using a private, proprietary checklist that is stricter than the clinical standard. The ASAM Criteria look at the whole person across six dimensions, including withdrawal risk, medical conditions, emotional and behavioral conditions, readiness to change, relapse risk, and the recovery environment. When a denial letter does not engage with those dimensions, that gap is often the strongest part of an appeal.

Why Residential Claims Get Denied

From the treatment-consulting side, the reasons behind a denial tend to fall into a small number of patterns. Knowing which one applies tells you what to fix.

  • Thin intake documentation: The assessment sent to the plan described substance use but did not document all six ASAM dimensions, so the reviewer saw only part of the picture.
  • “Fail first” reasoning: The reviewer suggested the person should try outpatient care before residential, even though the clinical standard matches the level of care to current need rather than to prior attempts.
  • Unaddressed recovery environment: The records did not explain that the person lives with active substance use, lacks stable housing, or has no safe place to be between outpatient sessions.
  • Missing co-occurring conditions: Depression, trauma, chronic pain, or other medical issues that raise the level of care were known to the family but never made it into the clinical record.
  • Administrative gaps: Prior authorization was not requested, the provider was out of network without an agreement in place, or paperwork arrived after a deadline.

The first four are clinical-documentation problems, and they are frequently fixable. The fifth is a process problem, and it often calls for a different conversation with the plan or the provider.

What to Do Today: Three Requests and One Check

If you are holding a denial right now, do not wait for the next business week. Make these requests of the health plan, in writing where you can, and keep a log with the date, time, and name of every person you speak with.

  1. Request the complete denial letter. A phone summary is not enough. The written notice should state the reason for the denial and explain your grievance and review rights.
  2. Request the specific clinical criteria used. Ask which criteria the reviewer applied and how the person’s situation fell short of them. Under SB 855, those criteria should be consistent with generally accepted standards such as the ASAM Criteria.
  3. Request the reviewer’s credentials. Ask whether a physician reviewed the case and what their specialty is. An addiction medicine or psychiatry background matters for this type of decision.

Then run one check: find out who regulates the plan. Most HMOs and many PPO plans in California are overseen by the Department of Managed Health Care. Some insurance policies are overseen by the California Department of Insurance, which runs its own independent review process. And many large employers use self-funded plans governed by federal ERISA rules, which are not subject to California’s state-level review. Your plan documents or HR department can tell you which applies. That single answer determines which appeal path you use.

Filing the Grievance: What a Strong Appeal Contains

A grievance is not a complaint letter. It is a clinical argument. The treating provider or admissions team usually writes the core of it, and the family adds what only the family knows. A strong appeal typically includes:

  • A letter from the assessing clinician that walks through each ASAM dimension and explains why residential is the appropriate level of care now.
  • Any history of prior treatment attempts, emergency visits, overdoses, or withdrawal complications.
  • Documentation of co-occurring mental health or medical conditions.
  • A plain description of the home environment and why outpatient care would leave the person without adequate support between sessions.
  • A request for a peer-to-peer review, in which the treating clinician speaks directly with the plan’s reviewer.

If the person is at serious risk, say so explicitly and ask for an expedited, or urgent, review. That is what triggers the shorter 3-day timeline.

When the Situation Cannot Wait

An insurance dispute should never decide whether someone gets safe medical care. Alcohol and benzodiazepine withdrawal can cause seizures and other life-threatening complications, and stopping either one requires medical supervision. Do not let a pending appeal lead to an unsupervised attempt to quit at home. If someone is showing signs of severe withdrawal, such as confusion, hallucinations, shaking, or a seizure, call 911 or go to the nearest emergency department. The National Institute on Drug Abuse and SAMHSA both emphasize that withdrawal from some substances needs medical management, not willpower alone.

If the person is in emotional crisis or thinking about suicide, call or text 988 to reach the 988 Suicide and Crisis Lifeline. For confidential treatment referral information at any hour, SAMHSA’s National Helpline is available at 1-800-662-4357.

What We See From the Placement Side

In placement work, the denials that get overturned tend to share one feature: someone went back and documented what the first review missed. Very often the family already knew the relevant facts, such as the two emergency room visits last year, the roommate who still drinks every night, or the panic attacks that started after the last attempt to cut back. Those facts simply never reached the plan. The single most useful thing a family can do is write those details down, in date order, and hand them to the clinician writing the appeal.

The second pattern is timing: you can start the grievance while exploring other options, and ask a provider whether care can begin while the review is pending.

If you want help checking benefits before admission, you can verify insurance through Bodhi in advance, which can surface prior-authorization requirements before they become a problem. To understand what the level of care itself involves, see our overview of residential treatment. And if you are weighing options after a denial, a treatment consultant can help match the clinical picture to programs and payment paths that fit.

Talk It Through With Someone Who Does This Every Week

A denial letter is written in the plan’s language. Getting it reversed usually means translating the person’s real situation back into the clinical language the plan is required to respect. You do not have to do that alone. Call Bodhi Addiction Treatment at (877) 328-1968 to talk through the denial, the appeal path that applies to your plan, and the options available while it is being resolved.

This article is for educational purposes only and is not medical, legal, or insurance advice. Appeal rights, timelines, and coverage rules vary by plan type and can change; confirm current requirements with your health plan and the appropriate state regulator. Never stop alcohol or benzodiazepines without medical supervision. If you or someone you love is in immediate danger, call 911. For emotional crisis support, call or text 988.

/by

Medications for Alcohol Use Disorder: Starting Naltrexone, Acamprosate, or Disulfiram Before You Leave Residential Treatment

, ,
Sunlit running trail through nature, representing the role of movement and exercise in early addiction recovery

Most people finishing residential treatment for alcohol use disorder leave with a discharge plan full of meetings, therapy appointments, and sober living options. Far fewer leave with a prescription. That gap is one of the most avoidable problems we see at discharge, and it usually comes down to logistics rather than clinical judgment: nobody started the medication early enough, the pharmacy fill was never confirmed, or the injectable was not authorized before the person walked out the door.

This guide covers what the approved medications are, how a residential program decides which one fits, and the practical steps that determine whether a medication plan actually survives the first week at home. If you are weighing treatment for yourself or someone you love, you can reach our admissions team at (877) 328-1968.

The Three Approved Medications for Alcohol Use Disorder

Three medications are currently approved in the United States to treat alcohol use disorder: naltrexone, acamprosate, and disulfiram, according to the National Institute on Alcohol Abuse and Alcoholism (NIAAA). None of the three is addictive. Naltrexone comes as a daily pill or a long-acting injection and reduces the urge to drink; acamprosate is a pill that eases the uncomfortable symptoms some people feel during early abstinence; and disulfiram is a pill that causes an unpleasant physical reaction if alcohol is consumed. Each can be used on its own or alongside counseling, and the right choice depends on liver and kidney function, other medications, and whether the goal is reducing cravings or building a hard deterrent.

A concern we hear almost every week from families is some version of “Isn’t that just swapping one drug for another?” The short answer is no. These medications do not produce a high, do not cause dependence, and are used the way a person might use a daily medication to manage blood pressure or asthma.

How Each Medication Works

Naltrexone blocks the reward signal: it reduces the pleasurable effect of alcohol and, for many people, the intensity of cravings, which makes it easier to stop after a slip rather than continue.

Acamprosate steadies early abstinence: it is thought to help rebalance brain chemistry disrupted by long-term heavy drinking, which can ease the restlessness, poor sleep, and irritability that often drive a return to alcohol in the first months.

Disulfiram creates a deterrent: it interferes with how the body breaks down alcohol, so drinking produces flushing, nausea, a pounding heart, and other symptoms that make alcohol deeply unappealing while the medication is active.

These are not interchangeable. Naltrexone is often a first choice for people whose main struggle is craving. Acamprosate is often favored for people with liver concerns, because it is cleared through the kidneys rather than the liver. Disulfiram tends to work best when someone is highly motivated and has a supportive person who helps with daily dosing. Your prescriber should explain why one is being recommended over the others.

Why Timing in Residential Treatment Matters

None of these medications treats alcohol withdrawal. Alcohol withdrawal can cause seizures and delirium tremens, which can be life-threatening. Stopping heavy, daily drinking requires medical supervision, and no one should try to detox from alcohol at home using any of these medications as a substitute. The same caution applies if benzodiazepines are also involved, because benzodiazepine withdrawal carries its own seizure risk and requires a supervised taper.

Once withdrawal has been medically managed, residential treatment is often the best window to start an AUD medication. In a residential setting, the care team can watch for side effects such as nausea, headache, or fatigue during the first days, adjust the dose, and switch medications if the first choice is not tolerated. That is much harder to do after discharge, when the first sign of trouble may simply be that the person stops taking the pill.

From practice, the single most useful rule is this: start the medication at least several days before discharge, not on discharge day. A person who leaves already taking a medication they have tolerated is far more likely to keep taking it than a person handed a new prescription on the way out.

Safety Checks Before Starting

Each medication has specific safety requirements that the medical team should review with you:

  • Naltrexone and opioids: naltrexone blocks opioids. A person who has recently used any opioid, including prescribed pain medication, can be pushed into sudden, severe withdrawal. The care team needs an accurate history and typically confirms a sufficient opioid-free period before starting it. Naltrexone also means opioid pain medication will not work normally, which matters for anyone facing surgery or dental work.
  • Naltrexone and the liver: prescribers usually check liver function before and during treatment.
  • Acamprosate and the kidneys: because acamprosate is cleared by the kidneys, kidney function affects the dose, and it may not be appropriate for people with severe kidney impairment. It is usually taken several times a day, which is worth planning around.
  • Disulfiram and hidden alcohol: disulfiram should never be given to anyone without their full knowledge and agreement, and never to someone who has been drinking recently. Reactions can be triggered by alcohol in products such as some mouthwashes, cough syrups, sauces, and hand sanitizers, and the effect can last for days after the last dose.

Tell the medical team about every medication and supplement you take, and about any history of liver disease, kidney disease, heart problems, or depression.

The Discharge Logistics That Decide Whether It Works

This is where plans fall apart, and it is almost never a medical failure. In our work coordinating discharges, the most common breakdowns are operational:

Unfilled prescriptions: the prescription was sent, but the pharmacy did not have it in stock, needed a prior authorization, or the person never picked it up.

No follow-up prescriber: the residential physician prescribed a 30-day supply, but no outpatient provider was lined up to continue it, so the medication ended when the bottle ran out.

Injectable timing: the long-acting naltrexone injection often requires insurance authorization and a clinic that stocks and administers it. If this is not arranged before discharge, the next dose can be missed entirely.

Insurance coverage for these medications varies by plan. Our team can check your benefits before admission through our insurance verification page, and our case management staff can help coordinate the outpatient prescriber and pharmacy before you leave.

Five Questions to Ask Before Your Discharge Date

Bring this list to your next meeting with your prescriber or case manager. Write down the answers.

  1. Which AUD medication are you recommending for me, and why that one rather than the other two?
  2. What date will I start it, and how many days will I take it here before I leave?
  3. Has the prescription been sent to my pharmacy, and has someone confirmed it is in stock and covered?
  4. Who is my outpatient prescriber, and what is the date of my first appointment with them?
  5. If I have side effects or a slip after discharge, who do I call, and should I keep taking the medication?

If any answer is “we’ll figure that out later,” ask for it to be resolved before discharge. A slip after treatment is not a reason to stop a medication without speaking to your prescriber; for naltrexone in particular, continuing it can help keep a single drink from becoming a return to heavy drinking.

Where to Find More Help

NIAAA’s Alcohol Treatment Navigator explains how to evaluate providers who offer medications along with behavioral treatment. SAMHSA’s National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day, 365 days a year for treatment referrals. For research on how alcohol use disorder affects the brain, the National Institute on Drug Abuse maintains additional resources.

At Bodhi Addiction Treatment in Northern California, medication for alcohol use disorder is discussed with every appropriate client as part of residential care, not treated as an afterthought at discharge. To talk through whether residential treatment and medication support fit your situation, call (877) 328-1968.

If you or someone you love is in crisis or thinking about suicide, call or text 988 to reach the 988 Suicide & Crisis Lifeline. If someone is having a seizure, is severely confused, or cannot be woken, call 911.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Medication decisions for alcohol use disorder should be made with a qualified health care provider who knows your full medical history. Never stop drinking abruptly after heavy, prolonged use without medical supervision.

/by

Medical Leave for Residential Treatment in California: FMLA, CFRA, and the Paperwork That Protects Your Job

,
A professional working on a laptop indoors — executive residential rehab remote-work track

Most people weighing residential treatment ask two questions first: will insurance cover it, and will I still have a job when I get back? The second question is often the one that quietly delays admission. This guide walks through how medical leave works for residential addiction treatment in California, what federal and state law actually protect, where the protection stops, and the paperwork steps you can start today.

The Short Answer: What Job-Protected Leave Covers

Under the federal Family and Medical Leave Act (FMLA), an eligible employee can take up to 12 workweeks of unpaid, job-protected leave in a 12-month period for a serious health condition, and treatment for a substance use disorder provided by or on referral from a health care provider can qualify. To be eligible, you generally must have worked for the employer for at least 12 months, logged at least 1,250 hours in the 12 months before leave starts, and work at a location where the employer has 50 or more employees within 75 miles. In California, the California Family Rights Act (CFRA) provides a similar 12 weeks and, since 2021, applies to employers with five or more employees, which brings many small-business workers under protection that FMLA alone would not give them. The U.S. Department of Labor summarizes the federal rules on its FMLA page.

The Distinction That Trips People Up

The protection attaches to treatment, not to substance use itself. That sounds like a technicality, but it has real consequences for timing.

  • Treatment is protected: Time away for residential care, detox, or other treatment from a qualified provider can be covered leave if you meet the eligibility rules.
  • Absences caused by use are not: Missing work because of drinking or drug use is generally not protected leave, even if you enter treatment later.
  • Existing workplace policies still apply: An employer may be able to act under a substance use policy that was established, communicated to employees, and applied consistently, even while you are on leave.
  • Requesting leave is not the same as disclosure to coworkers: Medical information you give HR for leave purposes is expected to be kept confidential and separate from your general personnel file.

The practical takeaway: if you are already worried about attendance or performance problems, asking for leave sooner rather than later usually puts you in a stronger position than waiting until a crisis forces the issue. If you have specific concerns about discipline, an employment attorney can review your situation; nothing here is legal advice.

What We See in Placement Work

In the placement calls our team handles, the bed and the insurance verification are often settled before the employment side is. People hold a start date open for days while they decide what to tell a manager, or while waiting for a form nobody has requested yet. Those days matter. Motivation for treatment tends to rise and fall, and a week spent waiting on paperwork is a week of continued use. The families who move fastest are usually the ones who treat the leave request as a parallel task, started the same day they call a program, rather than a step that has to finish first.

A second pattern: people frequently assume they must explain their diagnosis to their direct supervisor. In most workplaces, that is not how the process runs. Leave requests typically go to HR or a third-party leave administrator, and the medical certification goes from the provider to that office. Your manager usually needs to know dates and that you are on approved medical leave, not why.

Step by Step: Requesting Leave for Residential Treatment

  1. Find your leave policy today. Search your employee handbook or HR portal for “leave of absence,” “FMLA,” or “CFRA.” Note who administers leave: your HR department or an outside company.
  2. Check the three eligibility numbers. Confirm your start date (12 months of service), estimate your hours over the past year (1,250), and ask HR how many employees work within 75 miles of your site if you are relying on FMLA. In California, also ask whether CFRA applies, since the employer threshold is much lower.
  3. Give notice as early as you practically can. When leave is foreseeable, federal rules generally call for 30 days of notice; when it is not, notice as soon as practicable is usually acceptable. Residential admissions often happen within days, and that is common and workable.
  4. Ask for the certification form in writing. Your employer may require a medical certification from a health care provider. Request the form and the deadline in writing so nothing is lost.
  5. Route the form through the treatment program. Admissions or clinical staff at most licensed residential programs complete leave certifications routinely. Ask at intake who handles it and how quickly it is returned.
  6. Look at wage replacement separately. FMLA and CFRA leave is unpaid by law. In California, State Disability Insurance may partially replace wages for time you are unable to work due to a medical condition, and some employers offer short-term disability or allow paid time off to run alongside leave. Ask HR which applies to you.
  7. Put the return date on the calendar now. Residential stays are commonly planned in weeks, and step-down care such as PHP or outpatient may follow. Ask whether intermittent or reduced-schedule leave is available for ongoing appointments after you return.

If you want help coordinating these pieces with a program’s admissions team, you can reach Bodhi at (877) 328-1968.

A Safety Note on Timing

Some people try to “get ahead” of treatment by quitting alcohol or benzodiazepines on their own while they sort out work logistics. Please do not do this without medical guidance. Withdrawal from alcohol and from benzodiazepines can cause seizures and other serious complications, and medical supervision is required. If you are physically dependent on either, the safest plan is to keep the leave process moving while you arrange a medically supervised detox or admission, rather than stopping abruptly to buy time. Programs that follow ASAM Criteria assess withdrawal risk as part of deciding the appropriate level of care.

Why Stepping Away for Treatment Is Worth the Disruption

Taking weeks away from a job can feel like a risk you cannot afford. It helps to weigh it against what research-informed treatment offers. The National Institute on Drug Abuse notes in its principles of effective treatment that remaining in treatment for an adequate period of time is critical, and that effective care addresses the whole person, including employment and other life needs, not just substance use. A structured residential stay, followed by a clear continuing care plan, gives many people a way to return to work steadier than when they left.

You can learn more about what a stay involves on our residential treatment page, and you can confirm your coverage in parallel with your leave request through our insurance verification form.

Questions to Ask HR and the Program

Bring these to your next conversation so each call produces a concrete answer:

  • “Am I eligible for FMLA, CFRA, or both, and how many weeks do I have available?”
  • “What form do you need from my provider, and what is the deadline?”
  • “Can I use paid time off or short-term disability during the leave?”
  • To the program: “Who completes employer leave certifications, and how fast are they returned?”
  • To the program: “What does the step-down plan look like, and will I need intermittent leave for appointments afterward?”

If you are not sure which program or level of care fits, a treatment consultant can help match clinical needs with practical constraints like work schedules. For confidential, free referral information at any hour, SAMHSA runs a National Helpline at 1-800-662-4357. To talk with our team about admission timing, call (877) 328-1968.

The Bottom Line

Job-protected leave for addiction treatment exists, and for many California workers it is broader than they expect because CFRA reaches employers with as few as five employees. The protection covers treatment, not past absences caused by use, and the process runs on paperwork that you can start the same day you contact a program. Getting that paperwork moving early is often what keeps a start date from slipping.

Disclaimer: This article is for educational purposes only and is not medical or legal advice. Leave laws, eligibility, and employer policies vary, and rules can change. Confirm your rights with your employer, the U.S. Department of Labor, the California Civil Rights Department, or an employment attorney, and consult a qualified health care provider about your treatment. If you are in crisis, call or text 988 or call 911.

/by